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Метою роботи було визначення вмісту біологічно активних речовин, а саме поліфенолів та антоціанів,в 
екстрактах плодів аличі, чорниці, йошти, черешні, сливи, червоної та чорної смородини, та досліджен-
ня впливу екстрактів плодів цих рослин на ріст та біоплівкоутворенняклінічних ізолятів "збудників 
ESKAPE"in vitro.  
Матеріали і методи. Антибіотикорезистентність штамів клінічного походження, а саме Enterococcus 
faecalis, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, 
Enterobacter cloacae визначали методом дифузії Кірбі-Бауера. Вміст біологічно активних речовин визна-
чали методом тонкошарової хроматографії. Вплив ягідних екстрактів на вищезгадані ізоляти вивчали 
методом їх сумісного культивування. Здатність клінічних ізолятів до утворення біоплівки вивчали за 
допомогою спектрофотометричного методу з використанням кристалічного фіолетового, в якості ба-
рвника. 
Результати. Проаналізувавши результати чутливості до антибіотиків клінічних ізолятів, було вста-
новлено, що вони стійкі до всіх антимікробних препаратів. Аналіз вмісту біологічно активних речовин 
екстрактів ягід показав, що вони містять велику кількість антоціанів та поліфенолів, та володіють 
антибактеріальними властивостями. Було встановлено, що ізоляти клінічного походження здатні до 
біоплівкоутворення, а відібрані нами екстракти ягід володіють здатністю інгібувати сформовані біоп-
лівки ізолятами клінічного походження, а саме: Klebsiella pneumoniae та Pseudomonas aeruginosa. 
Висновки. Досліджуючи антибактеріальні властивості антоціанів та поліфенолів, екстрагованих з 
ягід, можна зробити висновок, що вони здатні гальмувати ріст не лише виділених нами планктонних 
форм штамів, але й пригнічують утворені ними біоплівки 
Ключові слова: ізоляти клінічного походження, біоплівки, екстракти їстівних рослин 
 
Copyright © 2019, O. Pallah, T. Meleshko, S. Tymoshchuk, L. Yusko, L. Bugyna. 
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0). 
 
1. Introductions 
Acronymically termed ESKAPE pathogens are 
able to escape the biological impact of antibiotics and 
collectively represent new paradigms in pathogenesis, 
transmission and resistance [1]. They are primarily 
known as agents of nosocomial diseases, those microbes 
that make the most detrimental complications to major 
diseases and often cause death [2]. 
In recent years ESKAPE Pathogens appeared to 
be among the most dangerous ones, with the highest fre-
quency of isolations in current hospital conditions [3]. 
The strategy for their prevention and effective treatment 
became one of the crucial challenges not only for dona-
tives, but also for other segments of the population. One 
of the intentions of the health care system is to solve this 
issue by deploying strong controlling over dissemination 
in the environment (including resistome) of the majority 
of ESKAPE Pathogens and prohibition for using antibiot-
ics for animal breeding and some other methodology.  
The first step was to specify the methods for re-
searching antibiotic sensitivity of clinical and non-
clinical isolates of opportunistic bacteria as confirmation 
of the feasibility of using and replenishment of EUCAST 
database and developing a newly created unified domes-
tic electronic resource [4]. The above-mentioned strains 
do not show any sensitivity to most of the currently 
known antibiotic agents. One of the ways to overcome 
the existing situation so far is the creation and develop-
ment of new antibiotics, which is a promising trend, 
though, in recent years, almost unknown. Another prom-
ising trend is the development of new antimicrobials of 
other (natural) origin, namely the use of bioactive sub-
stances (extracts), of not only medicinal but also edible 
plants. These promising antimicrobial compounds are al-
so defined by antioxidant (anti-inflammatory) and antibi-
ofilm-forming properties [5]. 
It is known, that polyphenolic compounds, includ-
ing anthocyanins, have the antimicrobial effect against a 
relatively wide range of microorganisms [6]. Anthocya-
nins exhibit the antimicrobial effect through induced cell 
damage by the destruction of a cell wall, membrane, and 
intercellular matrix [7]. 
 
2. Literary review 
Phenolic compounds are one of the most im-
portant bioactive substances that give fruits a relevant 
taste. Anthocyanins are pigments, responsible for the 
quality of fruit, and are markers of ripening, as most 
fruits accumulate anthocyanins only in the ripening phase 
[8]. Anthocyanins, glycosides of anthocyanidins are de-
rivatives of phenolic compounds and are natural plant 
pigments that give a color to fruit from red to purple. 
Previous studies showed that the alkaloids that are pre-
sent in berries have anti-diarrheal, antimicrobial and anti-
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inflammatory properties [9, 10]. Today, there are many 
papers, devoted to the use of anthocyanins in the treat-
ment of cancer [11, 12], the study of their biological 
properties [13]. The antioxidant activity of mahogany 
berries was studied and it was proved, that polyphenols, 
especially anthocyanins, are the main compounds, re-
sponsible for antioxidant properties of berries [14].  
Flavonoids are powerful antioxidants, free radical 
scavengers, and metal chelators; they inhibit lipid perox-
idation and exhibit different physiological effects: anti-
inflammatory, anti-allergic, anticarcinogenic, antihyper-
tensive, anti-arthritic and antimicrobial effects [15, 16]. 
 
3. The aim and objectives of the study 
The aim of the work was to determine the content 
of biologically active substances, namely polyphenols 
and anthocyanins, in the extracts of cherryplum, jostaber-
ries, blueberries, sweet cherries, plums, red and black 
currants, and to study the effect of these extracts on the 
growth and biofilm formation of clinical isolates of 
ESKAPE pathogens in vitro.  
To achieve the aim, the following tasks were set: 
1. To carry out the phytochemical screening of bi-
ologically active substances, namely to determine the 
gross content of anthocyanins and polyphenols in the ex-
tracts of berries and fruits of edible plants. 
2. To investigate the ability of edible plant ex-
tracts to inhibit the growth of ESKAPE Pathogens. 
3. To research the ability of edible plant extracts 
to inhibit biofilm formation by ESKAPE Pathogens. 
 
4. Materials and methods 
In our study, we used E. faecium, S. aureus, K. 
pneumoniae, A. baumannii, P. aeruginosa, Enterobacter 
spp. opportunistic pathogenic bacteria strains. 
The strains were isolated from patients of the 
Transcarpathian Regional Clinical Center for Neurosur-
gery and Neurology inpatient department and the Trans-
carpathian Regional Cardiology Health Center inpatient 
department according to methodological guidelines [17]. 
For strains, isolation and identification of microorgan-
isms of different genera, selective and chromogenic me-
dia were used as well as the following test systems: ОХІ 
test, ІNDOLtest, (produced by «PLIVA Lachema Diag-
nostika s.r.o.» Czech Republic), ENTERO-test 24, 
STREPTOtest16, STAPHYtest16, (PLIVA-Lachema di-
agnostica s.r.o, Brno city, Czech Republic). 
Antibiotic resistance of isolated strains 
Susceptibility determination of strains: E. faeci-
um, S. aureus, K. pneumoniae, A. baumannii, P. aeru-
ginosa, Enterobacter spp. to antibiotics was defined by 
the Kirby-Bauer diffusion method [18]. The effect of  
56 modern antibiotics, most commonly used in medicine 
to control pathogenic and opportunistic pathogens, was 
studied. 
Extraction of bioactive substances 
Methanol-free extracts of red currant (Ribes 
rubrum), sweet cherries (Prunus avium), plums (Prunus 
domestica), jostaberry (Ribes x nidigrolaria), blueberries 
(Vaccinium myrtillus), black currant (Ribes nigrum), 
cherry plum (Prunus cerasifera) were obtained by vacu-
um evaporation. 
We determined the quantitative content of poly-
phenols and anthocyanins in methanol extracts by thin-
layer chromatography (TLCH). We prepared the extract 
from 50 g of each kind of berries and used for extraction 
100 ml of methanol of 80 % concentration. To determine 
the gross content of biologically active substances, the 
optical density at 765 nm was measured and compared 
with a standard scale of gallic acid and cyanidin-3-
rutinoside [19, 20]. 
In order to study the antibacterial properties of 
berries extracts of edible plants, we used the method of 
cultivation of the studied extracts with previously select-
ed microorganisms: S. aureus, K. pneumoniae, P. aeru-
ginosa, Enterobacter spp. The initial concentration of the 
selected strains was 1.5 × 108 CFU / ml (N0). The ob-
tained data were expressed as the logarithm of the num-
ber of surviving bacteria (Nt) to the initial number of bac-
teria (N0) ˗ lg (Nt / N0) for a certain culturing time (4 h, 
14 h, and 24 h). For a positive control, we used selected 
strains of bacteria 1.5 × 108 CFU / ml, and for a negative 
control, plant extracts were used.  
To define the ability of clinical isolates to form 
biofilms, the suspensions of the tested microorganisms’ 
strains were prepared according to McFarland with 0.5  
of dullness, corresponding to a concentration of  
1.5 x 108 CFU / ml. 5 ml of the prepared bacterial sus-
pension were introduced into sterile testing tubes and 
cultured at 37 ° C for 5 days. 
After incubation, the contents of the testing tubes 
were removed and 3.5 ml of distilled water and 350 μl of 
1 % alcoholic solution of crystalline violet were added. 
The testing tubes were incubated for 45 min. at the room 
temperature. 
After incubation, the dye was removed and the 
testing tubes were washed three times with distilled wa-
ter. 4 ml of 96 % ethyl alcohol were added into washed 
testing tubes and left for 45 minutes at the room tempera-
ture. Thereafter, spectrophotometric measurements were 
performed at wavelengths of 630 nm and 492 nm. The op-
tical densities were measured on an SF-46 spectrophotom-
eter and a KFK-3 photoelectric colorimeter in quartz cells. 
Statistical processing of the results of experiments was 
carried out using a software OriginLab 2017 version 94E. 
 
5. Results and discussion 
We have analyzed the antibiotic sensitivity of 
ESKAPE Pathogens, isolated from patients of the Trans-
carpathian Regional Clinical Center for Neurosurgery 
and Neurology inpatient department and the Transcarpa-
thian Regional Cardiology Health Center inpatient de-
partment. From the obtained data, it was obvious that P. 
aeruginosa isolates were the highly resistant strains. On-
ly cefepime and vancomycin proved to be effective 
among 56 applied antibiotics (Table 1). The moderate re-
sistance was observed in relation to gatifloxacin, 
levofloxacin, meropenem, ciprofloxacin, gentamicin, 
ceftriaxone. K. pneumoniae strains were also character-
ized by the high resistance. The strains were sensitive on-
ly to gentamicin and phosphomycin out of all antibiotics 
used. E. faecalis strains were susceptible to 6 out of  
56 tested antibiotics, namely: nalidixic acid, ampicillin, 
netilmicin, rifampicin, ciprofloxacin, sparfloxacin. 
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S. aureus strains were susceptible only to gen-
tamicin, meropenem, nalidixic acid, oleandomycin, 
ciprofloxacinum, streptomycin, fosfomycin, azithromy-
cin, netilmicin. A. baumannii strains are also defined by 
the high polyresistance to the antibiotics. 
Enterobacter cloacae strains were susceptible to 
levofloxacin, amikacin, gentamicin, aztreonam, ampicil-
lin/sulbactam, netilmicin, rifampicin, ticarcilin, nalidixic 
acid, fosfomycin (200), ciprofloxacin.   
 
Table 1 
Antibiotic sensetivity of isolated strains from patients of the neurological department 
No. Antimicrobial agent Abbreviation 
Growth inhibition zone diameter (mm)±SD 
Species / 
quantity 
Species / 
quantity 
Species / 
quantity 
Species / 
quantity 
Species / 
quantity 
Species / 
quantity 
E. fae-
calis/10 
S. aureus 
/15 
K. pneu-
moniae /14 
A. bau-
mannii /12 
P.aeruginos
a /13 
E. cloacae 
/14 
1 Azithromycin AZM15 – 20±4 6±1.5 – 4±4.5 5±5 
2 Aztreonam AT30 0 21±0.6 6±0.6 –  6±1 
3 Amikacin AK30 – 16±0.58 0 9±0.58 0 21±1 
4 Ampicillin AMP10 22±1 6±0.58 0 3±0.58 0 0 
5 Ampicillin-sulbactam A/S10/10 6±1 7±1 6±0.58 0 12±0.57 8±2 
6 Amoxiclav AC30 9±1.5 8±1 7±0.57 4±0.57 – 6±2 
7 Amoxicillin AMX10 – 5±1.53 9±0.57 0 – – 
8 Amphotericin AP100 7±1.15 0 8±0.57 0 0 0 
9 Vancomycin VA30 14±0.6 0 0 15±0.57 23±0.57 6±1 
10 Gentamicin GEN10 9±1 21±1.53 21± 18±2 17±1.5 22±2.5 
11 Gatifloxacin  9±0.6 16±1.53 0 19±2 16±1 6± 
12 Doxycycline DO30 5±1.5 6±1.53 0 5±0.58 0 5±0.58 
13 Erythromycin E15 8±0.6 17±1.15 0 6±0.57 0 0 
14 Clindamycin CD2 6±1.4 4±1.15 0 6±0.57 0 7±1.5 
15 Clarithromycin CLR15 9±2.9 16±3.5 0 8±2 0 0 
16 Lincomicin L10 6±1 5±3.5 0 0 0 6±1 
17 Levofloxacin LE5 0 4±1 12± 17±2.5 17±3 0 
18 Meropenem МПН 7±0.58 20±1.52 0 19±2 17±2.5 6±0.57 
19 Moxifloxacin MO5 0 6±2.51 5± 16±2 0 6±0.57 
20 Metronidazole MT15 5±0.58 6±2.51 8±1 9±0.57 2±0.57 2±1 
21 Methilmicin MET5 13±3 18±0.57 7± 4±0.57 5±0.58 5±0.57 
22 Nalidixic acid  NA30 22±0.58 21±0.57 7±0.57 4±0.58 9±0.57 12±2 
23 Netilmicin NET30 21±2.52 20±0.57 5±1 4±0.57 8±0.58 9±0.57 
24 Nitroxoline  NO30 7±2 5±3.5 6±0.58 5±1.15 3±1 8±0.57 
25 Novobicin NV30 8±3 8±2.01 6±1.5 6±2.5 0 7±1 
26 Oleandomycin OL15 9±0.57 20±1.53 8±0.58 4±0.58 0 7±0.58 
27 Oxacillin OX5 10±0.57 9±2.52 8±0.57 0 0 6±0.58 
28 Ofloxacin OF5 7±0.57 6±0.58 8±0.58 0 0 5±0.58 
29 Benzylpenicillin P10 6±6 7±1.15 5±0.57 0 0 9±1.53 
30 Pipedimic acid PA30 6±0.57 17±3 0 0 0 8±0.57 
31 Polymyxin B PB300 12±0.57 5±2 16±2 6±0.57 0 16±0.57 
32 Piperacillin PI100 10±0,57 5±0.58 0 6±0.57 0 9±0.57 
33 Rifampicin RIF5 22±2 6±0.58 0 5±0.57 0 11±0.57 
34 Streptomycin S10 16±0.57 22±1.53 0 5±0.25 10±0.5 12±0.57 
35 Sparfloxacin SPX5 23±3 22±1 0 5± 7±0.5 8±2 
36 Spiramycin SR100 13±2 17±3 0 18±0.57 0 6±0.57 
37 Tetracycline TE30 12±0.57 8±1.53 5±0.57 7±1 0 11±0.57 
38 Tobramycin TOB10 10±3 6±1.53 5±0.57 4±0.57 0 – 
39 Ticarcillin  TI75 15±0.57 5±1.53 0 14±0.57 13±0.57 6±1.53 
40 Ticarcillin-clavulanic acid TCC75/10 17±1 0 7±1 8±1 0 – 
41 Fosfomycin  FO50 16±0.57 0 6±0.5 0 0 – 
42 Fosfomycin  FO200 19±0.57 21±2 22±2.5 5±0.57 7±0.57 15±0.57 
43 Furozalidone FR50 4±3,5 17±1.15 8±1 4±0.57 4±0.57 5±0.57 
44 Cefixime  CFM5 12±1.53 0 9±0.57 4±0.57 5±0.57 4±0.57 
45 Cefamandol CEF30 10±1.53 0 10±1 0   
46 Cefepime CPM30 8±1.53 0 0 0 22±2.5 6±1 
47 Cefotaxime CE10 7±1.55 0 3±0.57 14±2 12±1.5 6±1.5 
48 Ceftriaxone CTR30 10±1 0 5±0.5 16±1.53 18±1.53 6±0.57 
49 Cefoperazone CPZ75 – 0 0 15±1.53 0 6±0.57 
50 Cefazolin CZ30 12±2.5 0 0 8± 5±1.47 6±2 
51 Cefpodoxime  CEP10 10±0.57 0 5±0.57 7±0.53 9±0.57 0 
52 Ceftazidime CA30 9±0.57 0 0 0 11±1 6±2 
53 Ceftazidime-avibactam CAC30/10 7±0.57 0 5±0.57 8±0.57 7±0.57 9±0.57 
54 Cefoxitin  CN30 16±2.5 0 6±0.57 0 6±1.53 6±0.57 
55 Cefuroxime  CXM30 17±2 0 7±0.57 0 14±2 6±0.57 
56 Ciprofloxacin CF5 22±2.5 0 6±0.57 7±0.57 4±0.57 6±0.57 
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Having analyzed the results of antibiotic sensi-
tivity of strains, isolated from patients of the Trans-
carpathian Regional Cardiology Health Center inpa-
tient department (Table 2), we found E. faecalis 
strains to be resistant to almost all antibiotics, so it can 
be concluded, that this strain is more resistant than 
strains, isolated from patients of the Transcarpathian 
Regional Clinical Center for Neurosurgery and Neu-
rology. A. baumannii strains were not found among 
the isolated strains. This can be explained by the fact 
that different types of disinfectants are used to disin-
fect the premises of the inpatient departments of Neu-
rosurgery and Neurology Clinical Center and Cardiol-
ogy Health Center. As part of BacFoodNet project, it 
was revealed, that one of the effective methods of con-
trolling the polyresistance of nosocomial strains is the 
use of Cold Plasma Treatment [21]. 
Therefore, the use of antibiotic drugs is limited 
due to the polyresistance of isolated microorganisms that 
are related to nosocomial pathogens. 
 
Table 2 
Antibiotic sensitivity of isolated strains of patients from the cardiology health center 
No. Antimicrobial agent Abbreviation 
Growth inhibition zone diameter (mm) ±SD 
Species / 
quantity 
Species / 
quantity 
Species / 
quantity 
Species / 
quantity 
Species / 
quantity 
E. faecalis 
/13 
S. aureus 
/15 
K. pneumoniae 
/ 10 
P. aeruginosa / 
15 E. cloacae/ 13 
1 Ampicillin AMP10 12±2 6±1.53 0 0 0 
2 Ampicillin / sulbactam A/S10/10 6±1.53 6±1.15 6±0.57 12±2 3±1.15 
3 Amoxiclav AC30 9±1 9±2 8±1.53 5±1.15 6±1.15 
4 Bacitracin В10U 8±2 5±1.15 8±1.53 6±1.53 0 
5 Vancomycin VA30 10±0.58 0 0 3±0.58 0 
6 Gatifloxacin   9±0.58 6±1.15 0 7±0.58 0 
7 Doxycycline DO30 5±1.53 6±1.15 6±1.15 0 5±1.15 
8 Erythromycin E15 8±2.52 7±1.15 0 9±1.15 0 
9 Clindamycin CD2 6±1.73 4±0.58 5±1 0 7±1.15 
10 Clotrimazole СС10 4±1.15 5±1.15 8±0.58 5±1.52 3±0.58 
11 Imipen  4±2 9±1.15 5±1.52 3±1.15 0 
12 Levofloxacin LE5 0 4±0.58 3±1.15 3±1.15 0 
13 Meropenem МПН 5±1.52 10±1.52 0 7±1.15 6±0.58 
14 Netilmicin NET30 3±1.15 10±1.15 5±0.58 8±1.15 9±1.15 
15 Nystatin NS100U 11±0.58 12±1.52 9±1.53 9±0.58 8±1.52 
16 Oxacillin OX5 10±1 9± 8±1.53 0 0 
17 Pipemidic acid РА 3±0.58 7±0.58 8±0.58 9±0.58 5±1.52 
18 Rifampicin RIF5 4±1.52 6± 0 8±1.53 3±1.15 
19 Streptomycin S10 6±1.15 12±0.58 0 10±1.53 0 
20 Tetracycline TE30 8±1 8±1.52 5±1.15 0 8±1.53 
21 Ticarcilin TI75 5±0.58 5±1.53 0 13±1.52 6±1 
22 Fosphomycin FO200 4±1 11±0.58 12±0.58 7±1.53 6±0.58 
23 Furozalidone FR50 3±1 17±1.52 8±1.53 4±1 0 
24 Cefotaxime CE10 7±1.15 0 3±1 12±1.52 9±1.52 
25 Ceftriaxone CTR30 3±1.53 0 5±1.53 6±1.5 0 
26 Cefoperazone CPZ75 6±1.15 0 0 0 6±1 
27 Cefazolin CZ30 0 0 0 5±1 0 
28 Ciprofloxacin CF5 6±1.15 0 6±1 4±1.52 6±1 
 
The gross content of anthocyanin and polyphenol 
compounds was defined in methanolic berry extracts by 
thin-layer chromatography. According to the results of the 
study, presented in Table 3, the highest content of polyphe-
nols and anthocyanins was detected in the blueberry extract. 
The high content of anthocyanins and polyphenols was also 
found in the black currant extract, this can be explained by 
the fact that these berries have a dark color, which is provid-
ed by anthocyanins. Significantly less content of anthocya-
nins and polyphenols was found in jostaberry, red currant, 
plum, and sweet cherry extracts. The determination of an-
thocyanins and polyphenols gross content in the cherry 
plum extract showed no anthocyanins in this extract. It con-
tains polar phenols, such as catechin and flavonoids. 
 
Table 3 
Anthocyanins and polyphenols gross content in berries extracts 
No. Extracts Level of total anthocyanins, microg ekv. cyanidin-3-rutinoside/ml of extract 
Level of total polyphenolics, microg 
ekv. galic acid/ml of extract 
1 Cherry plum – 219 
2 Jostaberry 560.0 3250 
3 Sweet cherry 78.5 668 
4 Black currant 2886.2 5042 
5 Red currant 178.8 3962 
6 Blueberry 4779.277 8945 
7 Plum 18.8 525 
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Taking into account the results of gross content of 
anthocyanins and polyphenols in methanol extracts, we 
researched the ability of these extracts to inhibit the 
growth of opportunistic pathogens. For this purpose, non-
methanol extracts of berries were obtained by vacuum 
evaporation, which were used to study their antibacterial 
properties. 
We revealed (Table 4) that after 4 hours of incu-
bation the cherry plum extract had the antimicrobial ef-
fect against K. pneumoniae, E. cloacae, P. aeruginosa, 
S. aureus, the number of which significantly decreased. 
After 14 hours of incubation, no growth was observed 
in all strains, tested by us, except for K. pneumoniae, 
the number of which decreased. After 24 hours of ex-
tracts cultivation with selected strains the bacterial 
growth was absent. 
4-hour incubation of the sweet cherry extract with 
the tested microorganisms’ strains showed the low an-
tagonistic effect, compared to the cherry plum extract. 
The studied extract showed the antibacterial effect 
against E. cloacae, S. aureus strains, but P. aeruginosa 
strains were not susceptible to the impact of the sweet 
cherry extract. 
After 14 hours this extract showed the antibacteri-
al effect to all tested microorganisms. There was no 
growth of E. cloacae and S. aureus microorganisms. Af-
ter 24 hours of incubation no growth was observed in all 
microorganisms. 
In the combined cultivation of the plum extract 
with clinical isolates for 4 hours no antagonistic effect was 
observed against P. aeruginosa strain. However, the other 
strains were susceptible to the impact of the extract. After 
14 hours of incubation, there was no growth of S. aureus, 
E. cloacae, K. pneumoniae. The number of other microor-
ganisms’ strains decreased significantly. After 24 hours of 
incubation the growth of all strains was absent. 
After 4 hours of incubation, the antagonistic effect 
of jostaberry extract in P. aeruginosa was not observed. 
Other strains revealed the antibacterial effect of the ex-
tract. There was no growth of S. aureus and E. cloacae 
after 14 hours of incubation. Other strains showed the an-
tibacterial effect of the extract. After 24 hours, the num-
ber of tested microorganisms did not significantly de-
crease, compared to the data, obtained after 14 hours of 
incubation. The lack of growth is observed in 
P. aeruginosa, S. aureus only. 
The low antibacterial effect was shown by the red 
currant extract against E. cloacae and K. pneumoniae. 
After 14 hours of incubation, the number of mi-
croorganisms changed significantly. No growth was ob-
served in P. aeruginosa and K. pneumoniae, and no 
growth of S. aureus was observed after 24 hours of incu-
bation, in addition to the above-mentioned bacteria. 
After 4 hours of incubation, the weak antibacterial 
effect was shown by blueberry extract against E. cloacae. 
The number of microorganisms remained almost un-
changed in the subsequent incubation periods – 14 and 
24 hours, but was still less, compared to a similar one 
during 4-hour incubation. These extracts demonstrated 
the antagonistic effect on all tested strains. 
 
Table 4 
Biological influence of the fruit and berry extracts on the growth of Eskape Pathogens, in dynamics 
 K. pneumoniae P.aeruginosa S. aureus E. cloacae 
Treatment 
time, h 24 14 4 24 14 4 24 14 4 24 14 4 
Cherry plum –** –6.5± ±0.29* 
–5.2± 
±0.29* –** –** 
–2.5± 
±0.38* –** –** 
–3.13± 
±0.55* –** –** 
–4.17± 
±0.58 
Jostaberry –6.5± ±0.5 
–4.17± 
±0.5 
–2.5± 
±0.14 –** 
–6.5± 
±0.23 
–0,5± 
±0.29 –** –** 
–4.17± 
±0.27 –** –** 
–4.17± 
±0.29 
Sweet cherry –** –4.47± ±0.14 
–2.47± 
±0.29 –** 
–6.47± 
±0.29 
–0.47± 
±0.14 –** –** 
–4± 
±0.38 –** –** 
–5.17± 
±0.28 
Black currant –** –4.47 ±±0.29 
–4± 
±0.76 –** 
–6.47± 
±0.29 
–0.47± 
±0.29 –** –** 
–2± 
±0.25 
–3.17± 
±0.25 
–2.17± 
±0.29 
–2.17± 
±0.5 
Red currant –** –** –2.47± ±0,76 –** –** 
–4.47± 
±0.29 –** 
–6.47± 
±0.14 
–5.17± 
±0.29 
–3.17± 
±0.25 
–2.17± 
±0.29 
–2.17± 
±0.5 
Blueberry –** –4.47± ±0.29 
–3.87± 
±0.58 
–6.47± 
±0.29 
–6.47± 
±0.25 
–6.47± 
±0.29 –** 
–6.47± 
±0.14 
–4.36± 
±0.76 
–3.17± 
±0.25 
–2.17± 
±0.3 
–2.17± 
±0.25 
Plum –** –** –** 4±0.25 –** 
–** 
4.47± 
±0.29 
–** 
0.47± 
±0.29 
–** –** –6.47± ±0.29 –** –** 
–5.17± 
±0.29 
Note: Significant differences with the сherry plum extracts on growth of Eskape Pathogens by (P*<0.05); ** – bacteria growth is absent 
 
The most frequently isolated strains were K. 
pneumoniae and P. aeruginosa, accounting for up to 70 
% of selection frequency. Considering the fact that most 
bacteria do not exist in free-floating state but in formed 
associations – biofilms, we researched the ability of K. 
pneumoniae and P. aeruginosa strains, which did not 
show an antibiotic sensitivity, to form biofilms. 
Defining the optical density of K. pneumoniae and 
P. aeruginosa strains biofilms at the optical density of 
630 nm showed that for the first day of cultivation the val-
ues of the formed biofilm were in the range from 0.039 to 
0.026 units of optical density (UN OD). The greatest abil-
ity to form biofilms was observed in P. aeruginosa – 
0.039±0.001. K. pneumoniae biofilms were significantly 
less, but also at the high level – 0.026±0.003. Such an op-
tical density indicates that biofilm has begun to form. 
Starting on the second day, the optical density of sample 
biofilms increased, which was also observed during the 
third and fourth incubation days. The maximum optical 
density was reached on the fifth day of cultivation and 
made up 0.240±0.012 for P. aeruginosa and 0.135±0.005 
for K. pneumoniae, respectively. Analyzing the data, we 
came to the conclusion that the formation of a biofilm be-
gins on the first day of incubation. 
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Table 5 
The ability to biofim formation by P.aeruginosa, K. Pneumoniae at the optical density of 630 nm 
Bacteria 24 hours, UN OD±SD 
48 hours, UN 
OD±SD 
72 hours, UN 
OD±SD 
96 hours, UN 
OD±SD 
120 hours, UN 
OD±SD 
P.aeruginosa 0.039±0.001 0.075±0.006 0.186±0.005 0.236±0.03 0.240±0.012 
K. pneumoniae 0.026±0.003 0.045±0.007 0,118±0.005 0.128±0.001 0.135±0.005 
 
When analyzing the results, obtained at the wave-
length of 492 nm, as a whole, the values were lower than 
those, obtained at the wavelength of 630 nm. The range of 
values for P. aeruginosa was 0.023, and for K. pneumoni-
ae – 0.016 UN OD on the first day of incubation. Their 
maximum was reached on the fifth day of cultivation. 
The final stage of our study was to prove the an-
timicrobial ability of the extracts of edible plants to in-
hibit the growth of biofilms, formed by P. aeruginosa 
and K. pneumoniae strains. 
Comparing the values of the optical density of the 
formed biofilm and the measurement results after the im-
pact of the extract on the biofilms, we observed signifi-
cant differences, compared to planktonic forms. Thus, for 
P. aeruginosa strains, the optical density decreased to 
0.019±0.005 UN OD, and for K. pneumoniae – to 
0.001±0.001 UN OD (Table 7).  
Therefore, it can be concluded, that all the re-
searched extracts have antibacterial properties against 
biofilm formation. 
 
Table 6 
The ability to biofim formation by P.aeruginosa, K. Pneumoniae at the optical density of 492 nm 
Bacteria 24 hours, UN OD±SD 
48 hours, UN 
OD±SD 
72 hours, UN 
OD±SD 
96 hours, UN 
OD±SD 
120 hours, UN 
OD±SD 
P. aeruginosa 0.023±0.005 0.035±0.003 0.110±0.003 0.186±0.004 0.19±0.005 
K. pneumoniae 0.016±0.003 0.034±0.003 0.067±0.005 0.088±0.006 0.102±0.005 
 
Table 7 
The ability of dibble plant extracts to inhibit biofilm formation P. aeruginosa, K. pneumoniae 
Bacteria P.aeruginosa, OD±SD K. pneumoniae, OD±SD 
Extracts Control After treatment Control After treatment 
Cherry plum 0.240±0.012 0.019±0.01* 0.135±0.005 0.001±0.005* 
Jostaberry 0.240±0.012 0.022±0.008 0.135±0.005 0.015±0.008 
Sweet cherry 0.240±0.012 0.015±0.005 0.135±0.005 0.013±0.005 
Black currant 0.240±0.012 0.009±0.004 0.135±0.005 0.005±0.003 
Red currant 0.240±0.012 0.017±0.006 0.135±0.005 0.010±0.005 
Blueberry 0.240±0.012 0.014±0.005 0.135±0.005 0.008±0.005 
Plum 0.240±0.012 0.011±0.009 0.135±0.005 0.007±0.003 
 
 
The results were expressed as the mean ± standard 
deviation (SD) (*P<0.05) significant differences with the 
сherry plum extract on biofilm formation by P. aerugino-
sa, K. pneumoniae.  
 
6. Discussion 
The literature data analysis showed that the activi-
ty of polyphenols against gram-negative bacteria is high-
er, compared to gram-positive strains due to the outer 
membrane of gram-positive bacteria, which acts as a barri-
er to permeability, which leads to a decrease in the absorp-
tion of compounds into a cell. The mechanisms that are re-
sponsible for the toxicity of pure phenolic compounds to 
microorganisms include inhibition of enzyme by oxidized 
compounds, possibly through the reaction with sulfhydryl 
groups or through more nonspecific interactions with pro-
teins that lead to their inactivation and loss of function. 
However, analyzing the obtained experimental data, we 
found that the cherry plum extract, in which anthocyanins 
were not found, but flavonoids were present, inhibited the 
growth of both gram-positive and gram-negative bacteria. 
This extract showed the best antibacterial effect. Analyz
ing the obtained experimental data on antibacterial proper-
ties of jostaberry, sweet cherry, blueberry, plum, black 
currant and red currant extracts against the tested strains of 
microorganisms, virtually all strains proved to be suscepti-
ble, both gram-positive and gram-negative. They inhibited 
the growth of both gram-positive (S. aureus, E. cloacae) 
and gram-negative microorganisms (K. pneumoniae, P. 
aeruginosa). However, there is little information on the 
antimicrobial ability of phenols present in berries. In our 
studies, anthocyanin-rich extracts inhibited gram-negative 
and gram-positive bacteria. 
All the data, we obtained earlier, and the results of 
the studies in this paper demonstrate that the cherry plum 
extract possesses the best antibacterial effect. Other ex-
tracts also have a significant ability to inhibit the growth 
of microorganisms belonging to ESKAPE Pathogens, 
which makes them promising antibacterial agents. 
Antibacterial agents of biological origin in aerosol 
form can be used in medicine.  
The disadvantage of edible plant extracts is their 
limited shelf life due to the possibility of oxidation of bi-
ologically active compounds. 
7. Conclusions 
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1. The phytochemical analysis has revealed a high 
content of polyphenols and anthocyanins in the methanol 
extracts of edible fruits (cherry plum, jostaberry, 
blueberry, cherry, plum, red and black currants). The 
highest content of aforementioned phytochemicals was 
registered in the blueberry, the lowest one - in the plam. 
2. Methanol extracts of the investigated edible 
fruits exert the inhibitory effect on the growth of clinical 
isolates of ESKAPE pathogens. Most pronounced 
inhibitory effect was revealed for the extracts of cherry 
plum and plum, which contain the lowest amount of 
polyphenolics and anthocianins. 
3. Extracts of investigated edible fruits also inhibit 
biofilm formation by clinical isolates of ESKAPE 
pathogens. The most powerful inhibitory effect was 
registered for the extracts of black currant and cherry plum. 
Taking into account the safety of edible fruit extracts, they 
could be considered as promising antimicrobial agents. 
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